We are now just about two weeks away from the king of biotech and pharma events in cancer treatments. The 2012 annual meeting of the American Society of Clinical Oncology (ASCO) is set to take place … more →
24/7 Wall St.wrote 3 days ago: Buy or Sell: Sell Long Into Week 22 – 100% Cash Add to watchlist as initial or secondary buys … more →
wrote 1 week ago: Buy or Sell: Sell Long Into Week 21 – 100% Cash Add to watchlist as initial or secondary buys … more →
wrote 2 weeks ago: We are now just about two weeks away from the king of biotech and pharma events in cancer treatments … more →
wrote 2 weeks ago: Buy or Sell: Sell Long Into Week 20 – 100% Cash Add to watchlist as initial or secondary buys … more →
wrote 3 weeks ago: When we issued our earnings previews for the week ahead, it looked as though Dendreon Corporation (N … more →
wrote 3 weeks ago: When I updated the sector pages on 4.30.12, the glaring reduction in health care exposure, down from … more →
wrote 1 month ago: Earnings season is in full swing and we have many key reports due in the coming week. 24/7 Wall St. … more →
wrote 2 months ago: Dendreon Corp. (NASDAQ: DNDN), maker of prostate cancer drug Provenge, is once again rumored to be a … more →
wrote 2 months ago: You might have already heard the reports that Apple is sitting on a lot of cash, around the $100 bil … more →
wrote 2 months ago: The three major US equities indexes opened sharply lower this morning and the slide continued pretty … more →
wrote 2 months ago: Startling losses this morning, following several days of slowly deteriorating market conditions. Wh … more →
wrote 2 months ago: These are some of this Tuesday’s top analyst upgrades, downgrades, and initiations seen in Wal … more →
wrote 3 months ago: The Pharmaceutical Research and Manufacturers of America (PhRMA) has spoken out against the new 2013 … more →
wrote 3 months ago: The three major US stock indexes opened a bit higher this morning, and after some volatility have ma … more →
wrote 3 months ago: These are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street broker … more →
wrote 3 months ago: A US drug advisory panel today denied by a 12-1 vote permission for Amgen Inc. (NASDAQ: AMGN) to mar … more →
wrote 3 months ago: Credit Suisse is making a change in its Global Biotechnology outlook and says the is ‘room to … more →
wrote 4 months ago: All three major indexes opened higher this morning, but the strength didn’t last as the Chicago PMI … more →
wrote 4 months ago: These are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street broker … more →